HPV vaccine study found zero cases of cervical cancer among women vaccinated before age 14
On Jan. 25, 2024, an historic study out of Scotland showed the real-world impact of vaccines against the…
CCSL and Arcturus Therapeutics’ ARCT-154 Demonstrated Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster
On Dec. 21, 2023, CSL and and Arcturus Therapeutics announced the results of a Phase 3 study showing…
Biotechnology | Disease | Vaccine | WHO
R21/Matrix-M malaria vaccine granted prequalification by World Health Organization
On Dec. 21, 2023, the World Health Organization (WHO) announced that it had prequalified the R21/Matrix-M malaria vaccine…
COVID-19 vaccinations shifted to regular immunization as COVAX draws to a close
On Dec. 19, 2023, COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020,…
BioNTech aimed to start mRNA vaccine output in Rwanda in 2025
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in Taiwan
On Dec. 18, 2023, Novavax announced that the Taiwan Food and Drug Administration had granted emergency use authorization…
CEPI and PATH strengthen partnership to accelerate development of vaccines against diseases with epidemic potential
On Dec. 14, 2023, The Coalition for Epidemic Preparedness Innovations (CEPI) and PATH today announced a renewed collaboration…
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in the Republic of Korea
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in the Republic of Korea
On Nov. 29, 2023, Novavax’s partner, SK bioscience, announced that Novavax’s updated COVID-19 vaccine (NVX-CoV2601) had received Emergency…
Novavax’s updated protein-based COVID-19 vaccine now option for all 194 WHO member states
On Nov. 28, 2023, Novavax announced that Nuvaxovidï¾™ XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) had been granted Emergency Use Listing…
Japan’s MHLW approved CSL and Arcturus’s self-amplifying mRNA vaccine approved for COVID in adults
On Nov. 28, 2023, CSL and Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare (MHLW)…
University of Wisconsin-Madison reported spike in premature births caused by COVID, halted by vaccines
On Nov. 27, 2023, University of Wisconsin-Madison researchers released a study that showed COVID-19 caused an alarming surge…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Oncology | Therapeutics | Vaccine
CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
FDA approved first vaccine to prevent disease caused by chikungunya virus
On Nov. 9, 2023, the U.S. Food and Drug Administration approved Valneva’s Ixchiq, the first chikungunya vaccine. Ixchiq…
FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcal
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
Novavax received full Marketing Authorization for potype COVID-19 vaccine Nuvaxovid in UK
On Oct. 18, 2023, Novavax announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
Novavax’s prototype COVID-19 vaccine Nuvaxovid received full approval in Singapore
On Oct. 18, 2023, Novavax announced that Singapore’s Health Sciences Authority (HSA) has granted full approval for Novavax’s…
GSK and Zhifei announced exclusive strategic vaccine partnership in China with $3 billion
On Oct. 9, 2023, GlaxoSmithKline announced that it had reached an exclusive agreement with Chongqing Zhifei Biological Products…
Biotechnology | CDC | COVID-19 | Life Science News | Therapeutics | Vaccine
Novavax’s Nuvaxovid received positive CHMP opinion for full marketing authorization for prevention of COVID in the EU
On Oct. 3, 2023, Novavax announced that it’s COVID-19 Vaccine, Adjuvanted (2023-2024 Formula) (NVX-CoV2601) had received Emergency Use…
France kicked off world first bird flu vaccination despite trade backlash
On Oct. 2, 2023, France began vaccinating ducks against bird flu to try and stem the virus that…
Nobel Prize in medicine was jointly awarded to Katalin Kariko and Drew Weissman “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”
On Oct. 2, 2023, the Nobel Prize in Physiology or medicine was awarded jointly to Katalin Kariko and…
WHO recommended R21/Matrix-M vaccine for malaria prevention
On Oct. 2, 2023, the World Health Organization (WHO) announced it had recommended a new vaccine, R21/Matrix-M, developed…
USDA Protected U.S. Poultry with Restrictions on Poultry Products from France and the European Union
On Sept. 29, 2023, The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) announced it…
Pfizer and BioNTech received Health Canada authorization for XBB.1.5-adapted monovalent COVID-19 vaccine
On Sept. 28, 2023, Pfizer and BioNTech that Health Canada had authorized the companies’ Omicron XBB.1.5-adapted monovalent COVID-19…
Gritstone Bio awarded $433 Mmillion BARDA contract to conduct comparative phase 2b study evaluating next-generation vaccine candidate for COVID-19
On Sept. 27, 2023, Gritstone bio announced that it was awarded a contract by the Biomedical Advanced Research…
Clinical trial of HIV vaccine began in United States and South Africa
On Sept. 20, 2023, the National Institutes of Health announced that a trial of a preventive HIV vaccine…
![European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older](https://www.lifesciencehistory.com/wp-content/uploads/2022/06/european_commission_logo-768x768.jpg){kind=logo}
European Commission expanded Merck’s ERVEBO [Ebola Zaire vaccine] indication to include children 1 year of age and older
On Sept. 7, 2023, Merck announced that the European Commission (EC) had approved an expanded indication for ERVEBO…
Biotechnology | COVID-19 | FDA | Life Science News | Vaccine
Moderna clinical trial data confirmed updated Covid-19 vaccine generated strong immune response against BA.2.86 variant
On Sept. 6, 2023, Moderna announced that clinical trial data from its research assay confirm its updated COVID-19…
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
On Aug. 30, 2023, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…